Annals of Nuclear Medicine

, Volume 32, Issue 4, pp 239–249 | Cite as

Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay

  • Tetsuya Tsujikawa
  • Norihiko Narita
  • Masafumi Kanno
  • Tetsuji Takabayashi
  • Shigeharu Fujieda
  • Hidehiko Okazawa
Review Article


The American Joint Committee on Cancer (AJCC) released the 8th edition of the AJCC cancer staging manual in 2017 that includes significant modifications from the 7th edition in the sections on oral cavity cancer (OCC) and oropharyngeal cancer (OPC). These highlights comprise the incorporation of the depth of invasion and exclusion of extrinsic tongue muscle involvement in the T staging of OCC, the separation of OPC staging based on the high-risk human papilloma virus status, and the inclusion of extranodal extension in N staging. The recent introduction of integrated positron emission tomography and magnetic resonance imaging (PET/MRI) with 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) has demonstrated the advantages of simultaneous PET and MR imaging with higher soft-tissue contrast, multiplanar image acquisition, and functional imaging capability. This pictorial essay discusses the role of 18F-FDG PET/MRI in the diagnosis of OCC and OPC based on the new cancer staging system.


8th edition of the AJCC cancer staging system Oral cavity cancer Oropharyngeal cancer HPV 18F-FDG PET/MRI 


  1. 1.
    Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK et al, editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.Google Scholar
  2. 2.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  3. 3.
    Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.CrossRefPubMedGoogle Scholar
  4. 4.
    Boss A, Stegger L, Bisdas S, Kolb A, Schwenzer N, Pfister M, et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol. 2011;21:1439–46.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee SJ, Seo HJ, Cheon GJ, Kim JH, Kim EE, Kang KW, et al. Usefulness of integrated PET/MRI in head and neck cancer: a preliminary study. Nucl Med Mol Imaging. 2014;48:98–105.CrossRefPubMedGoogle Scholar
  6. 6.
    Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, et al. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med. 2014;55:551–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Kubiessa K, Purz S, Gawlitza M, Kühn A, Fuchs J, Steinhoff KG, et al. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:639–48.CrossRefPubMedGoogle Scholar
  8. 8.
    Tan WJ, Chia CS, Tan HK, Soo KC, Iyer NG. Prognostic significance of invasion depth in oral tongue squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2012;74:264–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases. J Oral Maxillofac Surg. 2013;71:775 – 85.CrossRefPubMedGoogle Scholar
  10. 10.
    International Consortium for Outcome Research (ICOR) in Head and Neck Cancer, Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, et al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140:1138–48.CrossRefGoogle Scholar
  11. 11.
    Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, et al. Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1192–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Maxwell JH, Ferris RL, Gooding W, Cunningham D, Mehta V, Kim S, et al. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer. 2013;119:3302–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Lam P, Au-Yeung KM, Cheng PW, Wei WI, Yuen AP, Trendell-Smith N, Li JH, Li R. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR. 2004;182:803–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014;32:3365–73.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society of Nuclear Medicine 2018

Authors and Affiliations

  • Tetsuya Tsujikawa
    • 1
  • Norihiko Narita
    • 2
  • Masafumi Kanno
    • 2
  • Tetsuji Takabayashi
    • 2
  • Shigeharu Fujieda
    • 2
  • Hidehiko Okazawa
    • 1
  1. 1.Biomedical Imaging Research CenterUniversity of FukuiFukuiJapan
  2. 2.Department of Otolaryngology, Faculty of Medical SciencesUniversity of FukuiFukuiJapan

Personalised recommendations